LEXARIA BIOSCIENCE CORP. Cost of Revenue
LEXARIA BIOSCIENCE CORP. (LEXX) reported Cost of Revenue of $14.38 thousand for the 3-month period ending 2015-11-30, per its 10-Q filed 2016-01-08.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2016-01-08
- LEXARIA BIOSCIENCE CORP. cost of revenue for the quarter ending 2015-11-30 was $14.38K.
- LEXARIA BIOSCIENCE CORP. cost of revenue for the quarter ending 2015-05-31 was $9.69K.
- LEXARIA BIOSCIENCE CORP. cost of revenue for the quarter ending 2015-02-28 was $2.05K.
- LEXARIA BIOSCIENCE CORP. cost of revenue for the quarter ending 2014-11-30 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. cost of revenue for fiscal 2013 was $795.20K, a 1.52% increase from fiscal 2012.
- LEXARIA BIOSCIENCE CORP. cost of revenue for fiscal 2012 was $783.27K, a 17.28% increase from fiscal 2011.
- LEXARIA BIOSCIENCE CORP. cost of revenue for fiscal 2011 was $667.86K, a 144.09% increase from fiscal 2010.
- LEXARIA BIOSCIENCE CORP. cost of revenue for fiscal 2010 was $273.62K.
| Period end | Cost of Revenue 2 month | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 10 month | Cost of Revenue 12 month |
|---|---|---|---|---|---|---|---|---|
| 2015-11-30 | $14.38K 10-Q · filed 2016-01-08 | |||||||
| 2015-05-31 | $9.69K 10-Q · filed 2015-07-14 | $11.74K derived: sum of 2 quarters · filed 2015-07-14 | $11.74K 10-Q · filed 2015-07-14 | |||||
| 2015-02-28 | $2.05K 10-Q · filed 2015-04-14 | $2.05K 10-Q · filed 2015-04-14 | ||||||
| 2014-11-30 | $0.00 10-Q · filed 2016-01-08 | |||||||
| 2014-08-31 | $0.00 10-KT · filed 2014-12-09 | |||||||
| 2014-07-31 | $82.10K 10-Q · filed 2014-11-14 | $319.11K 10-Q · filed 2014-11-14 | ||||||
| 2014-05-31 | $0.00 10-Q · filed 2015-07-14 | $0.00 10-Q · filed 2015-07-14 | ||||||
| 2014-04-30 | $110.30K 10-Q · filed 2014-06-12 | $237.01K 10-Q · filed 2014-06-12 | ||||||
| 2014-02-28 | $0.00 10-Q · filed 2015-04-14 | $0.00 10-Q · filed 2015-04-14 | ||||||
| 2014-01-31 | $126.71K 10-Q · filed 2014-03-12 | $358.32K derived: sum of 2 quarters · filed 2014-03-12 | $533.65K derived: sum of 3 quarters · filed 2014-11-14 | $698.75K derived: sum of 4 quarters · filed 2014-11-14 | ||||
| 2013-10-31 | $0.00 10-KT · filed 2014-12-09 | $231.61K derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-24 | $406.94K derived: sum of 2 quarters · filed 2014-11-14 | $572.04K derived: sum of 3 quarters · filed 2014-11-14 | $795.20K 10-K · filed 2014-01-24 | |||
| 2013-08-31 | $0.00 10-KT · filed 2014-12-09 | |||||||
| 2013-07-31 | $175.33K 10-Q · filed 2014-11-14 | $340.43K derived: sum of 2 quarters · filed 2014-11-14 | $563.60K 10-Q · filed 2014-11-14 | $829.16K derived: sum of 4 quarters · filed 2014-11-14 | ||||
| 2013-04-30 | $165.10K 10-Q · filed 2014-06-12 | $388.27K 10-Q · filed 2014-06-12 | $653.84K derived: sum of 3 quarters · filed 2014-06-12 | $883.18K derived: sum of 4 quarters · filed 2014-06-12 | ||||
| 2013-01-31 | $223.16K 10-Q · filed 2014-03-12 | $488.73K derived: sum of 2 quarters · filed 2014-03-12 | $718.08K derived: sum of 3 quarters · filed 2014-03-12 | $861.23K derived: sum of 4 quarters · filed 2014-03-12 | ||||
| 2012-10-31 | $265.57K derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-24 | $494.92K derived: sum of 2 quarters · filed 2014-01-24 | $638.06K derived: sum of 3 quarters · filed 2014-01-24 | $783.27K 10-K · filed 2014-01-24 | ||||
| 2012-07-31 | $229.35K 10-Q · filed 2013-09-10 | $372.49K derived: sum of 2 quarters · filed 2013-09-10 | $517.70K 10-Q · filed 2013-09-10 | $609.80K derived: sum of 4 quarters · filed 2013-09-10 | ||||
| 2012-04-30 | $143.15K 10-Q · filed 2013-06-12 | $288.35K 10-Q · filed 2013-06-12 | $380.45K derived: sum of 3 quarters · filed 2013-06-12 | $533.78K derived: sum of 4 quarters · filed 2013-06-12 | ||||
| 2012-01-31 | $145.21K 10-Q · filed 2013-03-13 | $237.30K derived: sum of 2 quarters · filed 2013-03-13 | $390.63K derived: sum of 3 quarters · filed 2013-03-13 | $602.42K derived: sum of 4 quarters · filed 2013-03-13 | ||||
| 2011-10-31 | $92.10K derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | $245.43K derived: sum of 2 quarters · filed 2013-01-29 | $457.21K derived: sum of 3 quarters · filed 2013-01-29 | $667.86K 10-K · filed 2013-01-29 | ||||
| 2011-07-31 | $153.33K 10-Q · filed 2012-09-12 | $185.26K 10-Q · filed 2011-09-14 | $365.11K derived: sum of 2 quarters · filed 2012-09-12 | $575.76K 10-Q · filed 2012-09-12 | $704.87K 10-Q · filed 2011-09-14 | $652.32K derived: sum of 4 quarters · filed 2012-09-12 | ||
| 2011-04-30 | $211.78K 10-Q · filed 2012-06-07 | $422.43K 10-Q · filed 2012-06-07 | $499.00K derived: sum of 3 quarters · filed 2012-06-07 | $581.92K derived: sum of 4 quarters · filed 2012-06-07 | ||||
| 2011-01-31 | $211.01K 10-Q · filed 2012-03-13 | $287.21K derived: sum of 2 quarters · filed 2012-03-13 | $370.14K derived: sum of 3 quarters · filed 2012-03-13 | |||||
| 2010-10-31 | $76.20K derived: 10-K 12 month − 10-Q 9 month · filed 2012-01-30 | $159.13K derived: sum of 2 quarters · filed 2012-01-30 | $273.62K 10-K · filed 2012-01-30 | |||||
| 2010-07-31 | $82.93K 10-Q · filed 2011-09-14 | $197.41K 10-Q · filed 2011-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |